NATALIE RUBINSTEIN: Open Payments
NPI 1174239768 · BENSALEM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,017 in 45 payments from 12 companies in 2025. Trend: 2023 $14 · 2024 $230 · 2025 $1,017
Food & beverage: $948Education: $69
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $336 |
| Organon LLC | 18 | $272 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $85 |
| LEO Pharma Inc. | 2 | $58 |
| Regeneron Healthcare Solutions, Inc. | 3 | $57 |
| Paratek Pharmaceuticals, Inc. | 2 | $40 |
| GENZYME CORPORATION | 1 | $36 |
| STRATA Skin Sciences, Inc. | 3 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| PFIZER INC. | 1 | $29 |
Products named: TREMFYA, VTAMA, DUPIXENT, ILUMYA, ADBRY, NUZYRA, XTRAC, COSENTYX.
Industry payments across PA — which companies pay providers there.
